Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by MOORE ALISON, Director. Officer active across 3 companies, notably CODEXIS, INC.. Aggregated, 10 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €61k. Activity tracked since 15 June 2021. The latest transaction was disclosed on 5 February 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
10 of 10 declarations
Alison Moore is a Board Member at Codexis, Inc. and Allogene Therapeutics, Inc. She brings expertise in technology and product development to the board. Her experience in the biopharmaceutical sector contributes to guiding the strategic decisions of the companies.